HENN MATTHEW R (Chief Scientific Officer) sold 4.5% of their position (3.95K shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2025ACC: 0000950170-25-023580
Officer· Chief Scientific Officer
Since Feb 2019
-3.95K
Net shares
Net seller
$3.2K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
10.63K acquired · 14.58K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2.81K
Price / share
—
Trade value
—
% of position
3.6%
2/15/2025
77.77K→80.58K
Common Stock
Direct
Shares
+7.81K
Price / share
—
Trade value
—
% of position
9.7%
2/15/2025
80.58K→88.40K
Common Stock
Direct
Shares
−3.95K
Price / share
$0.81
Trade value
$3.20K
% of position
4.5%
2/18/2025
88.40K→84.44K
Total
Net shares
+6.67K
Net value
-$3.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2025 | M · Option Exercise | +2.81K | — | — | 3.6% | 77.77K | 80.58K |
| Common Stock Direct | 2/15/2025 | M · Option Exercise | +7.81K | — | — | 9.7% | 80.58K | 88.40K |
| Common Stock Direct | 2/18/2025 | S · Sale | −3.95K | $0.81 | $3.20K | 4.5% | 88.40K | 84.44K |
| Total | +6.67K | -$3.20K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
2.81K shares
Shares
−2.81K
Strike price
Held after
22.50K
Exercisable
—
2/15/2025
Restricted Stock Units
Direct
Converts to
Common Stock
7.81K shares
Shares
−7.81K
Strike price
Held after
23.44K
Exercisable
—
2/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.81K shares | 2/15/2025 | M · Option Exercise | −2.81K | — | 22.50K | |
| Restricted Stock Units Direct | Common Stock7.81K shares | 2/15/2025 | M · Option Exercise | −7.81K | — | 23.44K |